Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/18/23 18:54 | 9/15/23 | ADVM | Health | BioPrd | Biological Products, (No Diag | Seyedkazemi Setareh | CA | O | Chief De | 1 | S | -9 | 1.52 | 0 | -6 | 48 | D | |||||||||||||||
3/17/23 18:02 | 3/15/23 | ADVM | Health | BioPrd | Biological Products, (No Diag | Riley Brigit | CA | O | Chief Sc | 1 | S | -6 | 0.7816 | 0 | -7 | 117 | D | |||||||||||||||
3/17/23 18:02 | 3/15/23 | ADVM | Health | BioPrd | Biological Products, (No Diag | Soparkar Peter | CA | O | COO | 1 | S | -10 | 0.7816 | 0 | -13 | 266 | D | |||||||||||||||
3/17/23 18:01 | 3/15/23 | ADVM | Health | BioPrd | Biological Products, (No Diag | Fischer Laurent | CA | DO | CEO,P,Di | 1 | S | -32 | 0.7816 | 0 | -41 | 692 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |